Prosecution Insights
Last updated: August 15, 2026

Sphingotec GmbH

6 pending office actions • 3 art units • 4 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (50%)
1
Medium (17%)
2
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§102 only1 (17%)
§112 only2 (33%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COUNTS, GARY W 2 59.0% +29.8%
SAOUD, CHRISTINE J 2 58.0% +37.6%
BOWLES, DAVID PAUL 1 69.4% +25.9%
MARCSISIN, ELLEN JEAN 1 34.0% +50.2%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
16781226 ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE SAOUD, CHRISTINE J 37d overdue
17635265 A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION IN PEDIATRIC PATIENTS COUNTS, GARY W 56d
17955765 METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT MARCSISIN, ELLEN JEAN

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17131008 METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT COUNTS, GARY W 71d overdue
16781226 ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE SAOUD, CHRISTINE J 37d overdue
16315805 ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE SAOUD, CHRISTINE J 36d overdue
17635265 A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION IN PEDIATRIC PATIENTS COUNTS, GARY W 56d
18568334 A METHOD FOR PREDICTING SEPSIS AND SEPTIC SHOCK BOWLES, DAVID PAUL
17955765 METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT MARCSISIN, ELLEN JEAN

Top Art Units

Art UnitApps
1678 2
1645 2
1677 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18568334 A METHOD FOR PREDICTING SEPSIS AND SEPTIC SHOCK BOWLES, DAVID PAUL §102 Non-Final OA Pending Dec 08, 2023
17955765 METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT MARCSISIN, ELLEN JEAN 1677 §101§112DP Final Rejection Pending Sep 29, 2022
17635265 A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION IN PEDIATRIC PATIENTS COUNTS, GARY W 1678 §102§103§112 Non-Final OA 56d Pending Feb 14, 2022
17131008 METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT COUNTS, GARY W 1678 §112 Non-Final OA 71d overdue Pending Dec 22, 2020
16781226 ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE SAOUD, CHRISTINE J 1645 §102§112 Non-Final OA 37d overdue Pending Feb 04, 2020
16315805 ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE SAOUD, CHRISTINE J 1645 §112 Final Rejection 36d overdue Pending Jan 07, 2019

Managing Sphingotec GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month